FDA approves first drug to prevent HIV infection

@article{Roehr2012FDAAF,
  title={FDA approves first drug to prevent HIV infection},
  author={B. Roehr},
  journal={BMJ : British Medical Journal},
  year={2012},
  volume={345}
}
  • B. Roehr
  • Published 2012
  • Medicine
  • BMJ : British Medical Journal
  • The US Food and Drug Administration this week approved for the first time a drug for use in the prevention of HIV infection. The drug, Truvada, is one of the most commonly used components of an anti-HIV “cocktail” regimen in the United States and Europe. Truvada is two drugs combined in a single pill, tenofovir disoproxil fumarate and emtricitabine. Its preventive use is commonly referred to as PrEP (pre-exposure prophylaxis). Studies in different groups at high risk of infection have shown… CONTINUE READING
    15 Citations
    GSK1265744 Demonstrates Robust In Vitro Activity Against Various Clades of HIV-1
    • 17
    Should we fear resistance from tenofovir/emtricitabine preexposure prophylaxis?
    • 38
    • Highly Influenced

    References

    Tenofovir works as pre-exposure prophylaxis against HIV, two studies confirm
    • B. Roehr
    • Medicine
    • BMJ : British Medical Journal
    • 2011
    • 12